PT1283838E - Compostos de piperazina e de piperidina - Google Patents

Compostos de piperazina e de piperidina

Info

Publication number
PT1283838E
PT1283838E PT01938214T PT01938214T PT1283838E PT 1283838 E PT1283838 E PT 1283838E PT 01938214 T PT01938214 T PT 01938214T PT 01938214 T PT01938214 T PT 01938214T PT 1283838 E PT1283838 E PT 1283838E
Authority
PT
Portugal
Prior art keywords
piperazine
piperidine compounds
piperidine
compounds
Prior art date
Application number
PT01938214T
Other languages
English (en)
Inventor
Roelof W Feenstra
Johannes A M Van Der Heijden
Cornelis G Kruse
Stephen K Long
Gustaaf J M Van Scharrenburg
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of PT1283838E publication Critical patent/PT1283838E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PT01938214T 2000-05-12 2001-05-10 Compostos de piperazina e de piperidina PT1283838E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201699 2000-05-12
PCT/EP2001/005320 WO2001085725A1 (en) 2000-05-12 2001-05-10 Piperazine and piperidine compounds

Publications (1)

Publication Number Publication Date
PT1283838E true PT1283838E (pt) 2004-04-30

Family

ID=8171488

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01938214T PT1283838E (pt) 2000-05-12 2001-05-10 Compostos de piperazina e de piperidina

Country Status (28)

Country Link
US (2) US6911448B2 (pt)
EP (1) EP1283838B1 (pt)
JP (1) JP2003532729A (pt)
CN (1) CN1174979C (pt)
AR (1) AR028443A1 (pt)
AT (1) ATE255578T1 (pt)
AU (2) AU2001263927B2 (pt)
BR (1) BR0110592A (pt)
CA (1) CA2405971C (pt)
CZ (1) CZ301464B6 (pt)
DE (1) DE60101386T2 (pt)
DK (1) DK1283838T3 (pt)
DZ (1) DZ3370A1 (pt)
ES (1) ES2211809T3 (pt)
HK (1) HK1055952A1 (pt)
HU (1) HUP0302016A2 (pt)
IL (2) IL152177A0 (pt)
MX (1) MXPA02011084A (pt)
NO (1) NO323778B1 (pt)
NZ (1) NZ522116A (pt)
PL (1) PL198857B1 (pt)
PT (1) PT1283838E (pt)
RU (1) RU2261250C2 (pt)
SK (1) SK286778B6 (pt)
TR (1) TR200302294T4 (pt)
UA (1) UA72337C2 (pt)
WO (1) WO2001085725A1 (pt)
ZA (1) ZA200208537B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE255578T1 (de) * 2000-05-12 2003-12-15 Solvay Pharm Bv Piperazin- und piperidinverbindungen
CA2453837C (en) * 2001-07-20 2011-10-04 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder using eltoprazine and related compounds
AU2003244160A1 (en) * 2002-06-25 2004-01-06 Sumitomo Pharmaceuticals Co., Ltd. Novel benzoxazolinone derivative
ES2232292B1 (es) * 2003-07-30 2006-11-01 Laboratorios Del Dr. Esteve, S.A. Compuestos sulfonamidicos derivados de benzoxazinona, su preparacion y uso como medicamentos.
US7596407B2 (en) 2004-03-26 2009-09-29 Solvay Pharmaceuticals, B.V. Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
EP1595542A1 (en) * 2004-03-26 2005-11-16 Solvay Pharmaceuticals B.V. Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
AR058022A1 (es) * 2005-08-22 2008-01-23 Solvay Pharm Bv Derivados de benzooxazoles, composiciones farmaceuticas y su uso para el tratamiento de desordenes del sistema nervioso.
US7750013B2 (en) 2005-08-22 2010-07-06 Solvay Pharmaceuticals, B.V. N-oxides as prodrugs of piperazine and piperidine derivatives
PT1919883E (pt) * 2005-08-22 2009-03-26 Solvay Pharm Bv N-óxidos como pró-medicamentos de derivados de piperazina & piperidina
US20070275977A1 (en) * 2006-05-02 2007-11-29 Van Aar Marcel P N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
US8106056B2 (en) 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
CA2670674A1 (en) 2006-12-07 2008-06-12 F. Hoffmann-La Roche Ag Spiro-piperidine derivatives as via receptor antagonists
WO2008068159A1 (en) 2006-12-07 2008-06-12 F. Hoffmann-La Roche Ag Spiro-piperidine derivatives
US7799923B2 (en) 2006-12-08 2010-09-21 Hoffmann-La Roche Inc. Indoles
AU2007328993B2 (en) 2006-12-08 2012-05-10 F. Hoffmann-La Roche Ag Indoles
RU2009123133A (ru) 2006-12-22 2011-01-27 Ф.Хоффманн-Ля Рош Аг (Ch) Производные спиро-пиперидина
EP2234990A1 (en) * 2008-01-15 2010-10-06 Abbott Healthcare Products B.V. Bifeprunox derivatives
JP7096813B2 (ja) 2016-08-26 2022-07-06 エクシーバ ゲーエムベーハー 組成物及びその方法
CN112513207B (zh) * 2018-07-27 2022-06-17 中国涂料株式会社 防污涂料组合物、防污涂膜、带有防污涂膜的基材及其制造方法以及修补方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60126275A (ja) * 1983-12-13 1985-07-05 Otsuka Pharmaceut Co Ltd ベンゾチアゾ−ル誘導体
FR2567884B1 (fr) 1984-07-19 1987-03-06 Roussel Uclaf Nouveaux derives de l'indole, leur preparation, leur application comme medicaments et les compositions les renfermant
DE3571436D1 (en) 1984-12-21 1989-08-17 Duphar Int Res New pharmaceutical compositions having anti-psychotic properties
DE3586794T2 (de) * 1984-12-21 1993-05-27 Duphar Int Res Arzneimittel mit psychotroper wirkung.
PL189256B1 (pl) * 1996-03-29 2005-07-29 Duphar Int Res Związki piperazyny i piperydyny, sposób ich wytwarzania, kompozycja farmaceutyczna zawierająca te związki, zastosowanie tych związków do wytwarzania leków
GB9811879D0 (en) * 1998-06-03 1998-07-29 Knoll Ag Therapeutic agents
UA71590C2 (en) * 1998-11-13 2004-12-15 Duphar Int Res Piperazine and piperidine derivatives
AU2001267421A1 (en) * 2000-05-12 2001-11-20 Solvay Pharmaceuticals B.V. Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders
ATE255578T1 (de) * 2000-05-12 2003-12-15 Solvay Pharm Bv Piperazin- und piperidinverbindungen

Also Published As

Publication number Publication date
EP1283838A1 (en) 2003-02-19
CA2405971A1 (en) 2001-11-15
US20030119849A1 (en) 2003-06-26
BR0110592A (pt) 2003-04-01
CN1174979C (zh) 2004-11-10
CZ301464B6 (cs) 2010-03-10
AR028443A1 (es) 2003-05-07
EP1283838B1 (en) 2003-12-03
CZ20023721A3 (cs) 2003-02-12
NZ522116A (en) 2004-04-30
IL152177A (en) 2009-08-03
AU2001263927B2 (en) 2004-09-30
NO20025365D0 (no) 2002-11-08
TR200302294T4 (tr) 2004-02-23
ZA200208537B (en) 2004-01-22
DE60101386D1 (de) 2004-01-15
CA2405971C (en) 2010-03-30
CN1429226A (zh) 2003-07-09
PL358201A1 (en) 2004-08-09
US20060089366A1 (en) 2006-04-27
US6911448B2 (en) 2005-06-28
SK15872002A3 (sk) 2003-04-01
JP2003532729A (ja) 2003-11-05
ATE255578T1 (de) 2003-12-15
ES2211809T3 (es) 2004-07-16
NO20025365L (no) 2002-11-08
IL152177A0 (en) 2003-05-29
US7297699B2 (en) 2007-11-20
NO323778B1 (no) 2007-07-02
UA72337C2 (uk) 2005-02-15
DE60101386T2 (de) 2004-05-27
HUP0302016A2 (hu) 2003-09-29
AU6392701A (en) 2001-11-20
DK1283838T3 (da) 2004-03-22
PL198857B1 (pl) 2008-07-31
HK1055952A1 (en) 2004-01-30
MXPA02011084A (es) 2003-03-10
SK286778B6 (sk) 2009-05-07
WO2001085725A1 (en) 2001-11-15
RU2261250C2 (ru) 2005-09-27
DZ3370A1 (fr) 2001-11-15

Similar Documents

Publication Publication Date Title
DK1325008T3 (da) Piperazinderivater
NO20023787L (no) Piperazin- og piperidinderivater
ATE397595T1 (de) Piperazin-derivate
AR028343A1 (es) Derivados de pirrolidina y piperidina
IS6546A (is) Nýjar píperazín afleiður
DE60103472D1 (de) Rohrschneider
DE50105915D1 (de) Schutzhülle
EE200300175A (et) Tsüanopürrolidiini derivaadid
ATE283800T1 (de) Dosendeckel
DE60000003T2 (de) Paroxetinmethansulfonat
PT1283838E (pt) Compostos de piperazina e de piperidina
NO20043079L (no) Piperazinderivat
DK1131308T3 (da) Piperazin- og piperidinderivater
NO20030276D0 (no) Fremgangsmåte
NO20023954D0 (no) Substituerte piperasinforbindelser
DE50113112D1 (de) Schaltungsanordnung
FI112705B (fi) Saranat
DK1202966T3 (da) Piperidinalkoholer
FI20001992A0 (fi) Impaktori
PT1131308E (pt) Novos compostos de piperazina e piperidina
DE60017876D1 (de) Müllverbrennungsofen
FI4651U1 (fi) Kaivo
FI20001398A (fi) Kaivo
FR2805803B1 (fr) Monte-materiaux
FR2814381B1 (fr) Dechiqueteur